Promoting Accountability in
Violation Tracker Parent Company Summary
|Top 10 Primary Offense Types||Penalty Total||Number of Records|
|off-label or unapproved promotion of medical products||$2,366,000,000||3|
|Foreign Corrupt Practices Act||$70,450,000||3|
|False Claims Act||$40,300,000||4|
|drug or medical equipment safety violation||$26,200,000||2|
|workplace safety or health violation||$11,278||1|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.
ACCLARENT; ADVANCED STERILIZATION PROD; ADVANCED STERILIZATION PROD DIVISION OF ETHICON; JANSSEN PHARMACEUTICA; JANSSEN PHARMACEUTICAL SB; JOHNSON AND JOHNSON; JOHNSON AND JOHNSON MEDICAL; LIFESCAN; McNeil-PPC Inc.; MICRUS; ORTHO MCNEIL PHARMACEUTICAL LLC; Scios Inc.; STERILMED
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
For more on the links between this company's federal political spending and its positions on proposed legislation, see its Maplight page.
Individual Penalty Records:
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|Johnson & Johnson||off-label or unapproved promotion of medical products||2013||FDA||$2,200,000,000|
|Scios Inc.||off-label or unapproved promotion of medical products||2011||FDA||$85,000,000|
|Ortho-McNeil Pharmaceutical LLC||off-label or unapproved promotion of medical products||2010||FDA||$81,000,000|
|Johnson & Johnson||Foreign Corrupt Practices Act||2011||SEC||$48,600,000|
|McNeil-PPC Inc.||drug or medical equipment safety violation||2015||FDA||$25,000,000|
|Johnson & Johnson||Foreign Corrupt Practices Act||2011||DOJ_CRIMINAL||$21,400,000|
|Acclarent Inc.||False Claims Act||2016||DOJ_CIVIL||$18,000,000|
|Lifescan, Inc.||False Claims Act||2001||DOJ_CIVIL||$15,000,000|
|Johnson & Johnson Medical, Inc.||False Claims Act||2001||DOJ_CIVIL||$3,900,000|
|Ortho McNeil Pharmaceutical||False Claims Act||2009||DOJ_CIVIL||$3,400,000|
|Advanced Sterilization Products, a division of Ethicon Inc.||drug or medical equipment safety violation||2013||FDA||$1,200,000|
|Micrus Corporation||Foreign Corrupt Practices Act||2005||DOJ_CRIMINAL||$450,000|
|Advanced Sterilization Products||environmental violation||2014||EPA||$136,800|
|Advanced Sterilization Products, Division of Ethicon||environmental violation||2014||EPA||$136,800|
|Janssen Pharmaceutical (SB)||environmental violation||2010||EPA||$105,000|
|STERILMED, INC.||workplace safety or health violation||2006||OSHA||$11,278|
|Janssen Pharmaceutica Inc.||environmental violation||2004||EPA||$7,700|
|Johnson & Johnson||environmental violation||2004||EPA||$5,000|